纽约州成人终末期肾病患者门诊抗生素处方模式
该回顾性病例对照研究分析2016至2017年纽约州终末期肾病(ESRD)与非ESRD患者的门诊抗生素处方,发现ESRD患者抗生素暴露率与处方发生率均显著更高,且36%的甲氧苄啶-磺胺甲噁唑剂量超出当前ESRD指南推荐,提示需加强抗生素教育及门诊管理。
要点
- ESRD患者接受抗生素的比例为520.29/1000,显著高于非ESRD患者的296.48/1000(P < .05)。
- ESRD患者抗生素处方发生率为1359.95/1000,非ESRD患者为673.61/1000。
- 36%的甲氧苄啶-磺胺甲噁唑处方剂量高于当前ESRD指南推荐。
核心结论
- ESRD患者门诊抗生素暴露率和处方发生率均显著高于非ESRD患者,且部分抗生素剂量不当,支持开展门诊抗生素管理项目。
研究设计与样本
- 2016至2017年纽约州ESRD与非ESRD患者的回顾性病例对照研究,分析Medicare Part B和Part D账单数据。
- 另分析一个约2200例患者的纽约州小型透析组织。
主要发现
- ESRD患者接受抗生素比例为520.29/1000,非ESRD患者为296.48/1000(P < .05)。
- ESRD患者抗生素处方发生率为1359.95/1000,非ESRD患者为673.61/1000。
- ESRD患者前三大感染类别为非特异性症状、皮肤和呼吸道;非ESRD患者为呼吸道、非特异性症状和泌尿生殖道。
关键数值与推荐
- 36%的甲氧苄啶-磺胺甲噁唑剂量按当前ESRD指南评估为偏高。
临床怎么用
- 应加强对肾科及非肾科医生的抗生素教育,推动门诊抗生素管理项目。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infections are important complications of end-stage renal disease (ESRD) with few studies having investigated oral antibiotic use. Inappropriate antibiotic prescribing can contribute to multidrug-resistant organisms and Clostridioides difficile infections seen in ESRD. This study investigates antibiotic prescribing practices in ESRD across New York State (NYS). METHODS: Retrospective case-control study from 2016 to 2017 of NYS ESRD and non-ESRD patients analyzing Medicare part B billing codes, 7 days before and 3 days after part D claims. Frequencies of each infection, each antibiotic, dosages, and the antibiotics associated with infections were assessed using χ 2 analysis. A NYS small dialysis organization comprising approximately 2200 patients was also analyzed. Outcomes measured were the frequencies of infections and of each antibiotic prescribed. Incidence measures included antibiotics per 1000 and individuals receiving antibiotics per 1000. RESULTS: A total of 48 100 infections were treated in 35 369 ESRD patients and 2 544 443 infections treated in 3 777 314 non-ESRD patients. ESRD patients were younger, male, and African American. ESRD and non-ESRD patients receiving antibiotics was 520.29/1000 and 296.48/1000, respectively (P < .05). The prescription incidence was 1359.95/1000 ESRD vs 673.61/1000 non-ESRD patients. In 36%, trimethoprim-sulfamethoxazole dosage was elevated by current ESRD guidelines. Top infectious categories included nonspecific symptoms, skin, and respiratory for ESRD; and respiratory, nonspecific symptoms, and genitourinary in non-ESRD. CONCLUSIONS: This study identifies issues with appropriate antibiotic usage stressing the importance of antibiotic education to nephrologist and nonnephrologist providers. It provides support for outpatient antibiotic stewardship programs.
引用
- Coritsidis GN, Yaphe S, Rahkman I, et al. Outpatient Antibiotic Prescribing Patterns for Adult End-Stage Renal Disease Patients in New York State. Clin Infect Dis. 2021. PMID: 33277995. doi:10.1093/cid/ciaa1801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。